HHS awards additional $487 million to states for opioid response

Mar 22, 2019 - 02:26 PM
Department of Health and Human Services (HHS) Seal

The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to medication-assisted treatment for opioid use disorder and reduce opioid overdose deaths. “Strategies such as employing psychosocial supports, community recovery services and MAT using medicines approved by the [Food and Drug Administration] constitute the gold standard of treatment for opioid use disorders,” said Assistant Secretary for Mental Health and Substance Use Elinore McCance-Katz, M.D. The 10 states with the highest overdose mortality rates received 15 percent of the funding. HHS expects to award another $933 million in state opioid response grants later this year as part of its five-point opioid strategy, launched a year ago this week.

Related News Articles

Headline
FDA issues guidance to expand non-opioid treatments for chronic pain
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
Study finds less than 40% of Medicare beneficiaries with OUD receive standard care
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
FDA announces labeling changes to opioid pain medications 
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
Overdose deaths dropped an estimated 27% in 2024
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
FDA approves first-in-class non-opioid painkiller 
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…